Evidence map›Paper›PMID 34820019›Full record

ArticleAnnals of thoracic medicine

Drug susceptibility profiling of pulmonary

Priya Rajendran, Chandrasekaran Padmapriyadarsini, Vaishnavee Vijayaraghavan, Tamizhselvan Manoharan, Lakshana Malla Lokanathan, Parveen Banu Kadhar, Lavanya Jayabal, Gomathy Sivaramakrishnan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of thoracic medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Molecular Characterisation ofPathogens (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Priya RajendranDepartment of Bacteriology, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Chandrasekaran PadmapriyadarsiniDepartment of Clinical Research, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Vaishnavee VijayaraghavanDepartment of Bacteriology, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Tamizhselvan ManoharanDepartment of Statistics, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Lakshana Malla LokanathanDepartment of Clinical Research, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Parveen Banu KadharDepartment of Bacteriology, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Lavanya JayabalDistrict TB Office, Chennai, Tamil Nadu, India.
Gomathy SivaramakrishnanDepartment of Bacteriology, ICMR -National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
National Institute of Research in Tuberculosis · INTamil Nadu Board of Rural Development · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWith the introduction of newer molecular diagnostic tools to identify

methodsA wide profile of NTM species were reported earlier from a prospective cohort of adults during 2017-2020. Out of this profile, a total of 22

resultsOut of the 18 strains of

conclusionThere was a poor correlation between the treatment outcome and the resistance pattern of the antibiotics tested. With increasing numbers of NTM being reported, early and correct identification of NTM species is essential for the prompt initiation of appropriate treatment to achieve better outcome.

Indexed as

Drug regimendrug susceptibility testingmisdiagnosisMycobacterium kansasiinontuberculous mycobacteriumtuberculosis

Identifiers

PMID34820019
PMCPMC8588942
OpenAlexW3210272498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.